759 results on '"Mancini, Donna M."'
Search Results
2. Abstract 19069: Empagliflozin Improves Right Ventricular Remodeling and Right Ventricular Systolic Function in Non-Diabetic Hfref: Insights From Porcine and Human Studies
3. Frailty Measures of Patient-reported Activity and Fatigue May Predict 1-year Outcomes in Ambulatory Advanced Heart Failure: A Report From the REVIVAL Registry
4. Use of Cardiopulmonary Stress Testing for Patients With Unexplained Dyspnea Post–Coronavirus Disease
5. Predictive Value of Cardiopulmonary Exercise Testing Parameters in Ambulatory Advanced Heart Failure
6. Abstract 15813: Comparative Case Series of Biventricular Support Between Heartmate-3 Ventricular Assist Devices and the Total Artificial Heart: A Single-Center Experience
7. Diagnosis of Heart Failure
8. Hemodynamic Response to Exercise in Patients Supported by Continuous Flow Left Ventricular Assist Devices
9. Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL): Rationale, design, baseline characteristics, and inclusion criteria performance
10. Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation
11. Frequency and Clinical Implications of Referrals to Heart Failure Among Patients with Peripartum Cardiomyopathy.
12. The Need for Speed
13. Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection
14. Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry
15. Diagnosis of Heart Failure
16. Abstract 17275: The SGLT2 Inhibitor Empagliflozin Ameliorates Left Atrial Dilatation in Non-Diabetic Patients With Heart Failure With Reduced Ejection Fraction: A Secondary Analysis of the EMPATROPISM Trial
17. Abstract 17157: The SGLT2 Inhibitor Empagliflozin Ameliorates Interstitial Myocardial Fibrosis and Aortic Stiffness in Non-Diabetic Patients With Heart Failure With Reduced Ejection Fraction: A Secondary Analysis of the EMPATROPISM Trial
18. The New Adult Heart Allocation Policy: A Work in Progress
19. Atrial Fibrillation in Patients With Left Ventricular Assist Devices: Incidence, Predictors, and Clinical Outcomes
20. Management of Non-cardiac Co-morbidities in Chronic Heart Failure
21. The Impact of Obesity on Patients Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices
22. Analysis of Skeletal Muscle Torque Capacity and Circulating Ceramides in Patients with Advanced Heart Failure
23. Comparison Between Cardiac Allograft Vasculopathy and Native Coronary Atherosclerosis by Optical Coherence Tomography
24. Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device
25. Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure
26. Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset
27. Concomitant aortic valve repair with continuous-flow left ventricular assist devices: Results and implications
28. Outcomes of Multiple Listing for Adult Heart Transplantation in the United States: Analysis of OPTN Data From 2000 to 2013
29. The Need for Speed
30. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival
31. Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome
32. Mechanical Circulatory Support as a Bridge to Cardiac Retransplantation: A single center experience
33. Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support
34. Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement
35. Effect of Peripheral Vascular Disease on Mortality in Cardiac Transplant Recipients (from the United Network of Organ Sharing Database)
36. Advanced heart failure in patients infected with human immunodeficiency virus: Is there equal access to care?
37. Reduced Handgrip Strength as a Marker of Frailty Predicts Clinical Outcomes in Patients With Heart Failure Undergoing Ventricular Assist Device Placement
38. Management of Comorbidities in Heart Failure
39. Longitudinal profiling of circulating miRNA during cardiac allograft rejection: a proof‐of‐concept study
40. Increased coronary lipid accumulation in heart transplant recipients with prior high-grade cellular rejection: novel insights from near-infrared spectroscopy
41. Chest-Wall Adipose Tissue Excisional Biopsy During Pacemaker or Defibrillator Implantation
42. De novo human leukocyte antigen allosensitization patterns in patients bridged to heart transplantation using left ventricular assist devices
43. Safety and effects of SGLT-2 inhibitor use among LVAD patients with type 2 diabetes mellitus
44. Recipient Selection
45. Cardiac Transplantation
46. Relation of Preoperative Serum Albumin Levels to Survival in Patients Undergoing Left Ventricular Assist Device Implantation
47. Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation
48. Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure
49. Cardiac Transplantation in Adult Patients with Mental Retardation: Do Outcomes Support Consensus Guidelines?
50. Reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.